| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.783 | 0.004 | 0.797 | 5 Hydroxytryptamine release stimulant | 0.797 0.004 CID_903 0.74 0.005 CID_1864 | CID_903 | |
| 0.677 | 0.001 | 0.677 | Melatonin receptor 1A agonist | 0.266 0.002 CID_903 0.276 0.002 CID_1864 0.034 0.023 CID_131769970 | ||
| 0.638 | 0.002 | 0.638 | Melatonin 1 agonist | 0.476 0.003 CID_903 0.458 0.003 CID_1864 0.103 0.004 CID_131769970 | ||
| 0.622 | 0.002 | 0.622 | Melatonin agonist | 0.457 0.003 CID_903 0.432 0.003 CID_1864 0.131 0.004 CID_131769970 | ||
| 0.619 | 0.001 | 0.619 | Melatonin receptor 1A antagonist | 0.14 0.002 CID_903 0.224 0.002 CID_1864 | ||
| 0.58 | 0.003 | 0.58 | Melatonin antagonist | 0.385 0.003 CID_903 0.326 0.003 CID_1864 0.09 0.005 CID_131769970 | ||
| 0.568 | 0.002 | 0.568 | Melatonin 2 agonist | 0.455 0.003 CID_903 0.446 0.003 CID_1864 0.116 0.004 CID_131769970 | ||
| 0.581 | 0.039 | 0.721 | Caspase 9 stimulant | 0.536 0.048 CID_903 0.721 0.021 CID_1864 0.485 0.066 CID_131769970 | CID_1864 | |
| 0.556 | 0.015 | 0.605 | Interleukin antagonist | 0.605 0.012 CID_903 0.549 0.016 CID_1864 0.158 0.112 CID_131769970 | CID_903 | |
| 0.505 | 0.003 | 0.505 | Melatonin 1 antagonist | 0.304 0.003 CID_903 0.257 0.003 CID_1864 0.065 0.004 CID_131769970 | ||
| 0.492 | 0.004 | 0.492 | 5 Hydroxytryptamine 1E antagonist | 0.453 0.004 CID_903 0.396 0.005 CID_1864 | ||
| 0.444 | 0.017 | 0.46 | Psychostimulant | 0.46 0.015 CID_903 0.443 0.017 CID_1864 0.384 0.025 CID_131769970 | CID_903 | |
| 0.45 | 0.041 | 0.524 | Vasodilator, peripheral | 0.44 0.044 CID_903 0.482 0.032 CID_1864 0.524 0.024 CID_131769970 | CID_131769970 | |
| 0.397 | 0.001 | 0.397 | Melatonin 2 antagonist | 0.053 0.002 CID_903 0.069 0.002 CID_1864 | ||
| 0.443 | 0.055 | 0.495 | Calcium channel L-type activator | 0.495 0.03 CID_903 0.477 0.037 CID_1864 | CID_903 | |
| 0.448 | 0.063 | 0.448 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.444 0.066 CID_903 0.316 0.191 CID_1864 | ||
| 0.382 | 0.005 | 0.382 | 5 Hydroxytryptamine 1 agonist | 0.323 0.005 CID_903 0.212 0.01 CID_1864 | ||
| 0.398 | 0.022 | 0.44 | Insulysin inhibitor | 0.44 0.016 CID_903 0.411 0.02 CID_1864 | CID_903 | |
| 0.341 | 0.003 | 0.341 | 5 Hydroxytryptamine 3E antagonist | 0.326 0.004 CID_903 0.235 0.024 CID_1864 | ||
| 0.323 | 0.003 | 0.379 | Myeloperoxidase inhibitor | 0.378 0.003 CID_903 0.379 0.003 CID_1864 | CID_1864 | |
| 0.321 | 0.008 | 0.345 | Nitric-oxide synthase stimulant | 0.345 0.005 CID_903 0.34 0.005 CID_1864 0.167 0.159 CID_131769970 | CID_903 | |
| 0.324 | 0.04 | 0.437 | Amyloid beta aggregation inhibitor | 0.369 0.03 CID_903 0.437 0.02 CID_1864 | CID_1864 | |
| 0.339 | 0.057 | 0.339 | Calcium channel activator | 0.286 0.106 CID_903 0.326 0.068 CID_1864 | ||
| 0.361 | 0.08 | 0.529 | GABA C receptor rho-3 antagonist | 0.529 0.019 CID_903 0.298 0.117 CID_1864 | CID_903 | |
| 0.277 | 0.004 | 0.277 | Acetylcholine release stimulant | 0.179 0.006 CID_903 0.172 0.008 CID_1864 0.158 0.013 CID_131769970 | ||
| 0.301 | 0.027 | 0.615 | DNA methylase inhibitor | 0.302 0.027 CID_903 0.434 0.009 CID_1864 0.615 0.004 CID_131769970 | CID_131769970 | |
| 0.294 | 0.029 | 0.594 | DNA methyltransferase I inhibitor | 0.296 0.028 CID_903 0.426 0.007 CID_1864 0.594 0.004 CID_131769970 | CID_131769970 | |
| 0.295 | 0.032 | 0.295 | Calpain inhibitor | 0.294 0.033 CID_903 0.27 0.048 CID_1864 | ||
| 0.263 | 0.007 | 0.337 | Toll-Like receptor 2 antagonist | 0.314 0.004 CID_903 0.337 0.004 CID_1864 | CID_1864 | |
| 0.264 | 0.01 | 0.264 | 5 Hydroxytryptamine agonist | 0.191 0.015 CID_903 0.132 0.025 CID_1864 | ||
| 0.268 | 0.018 | 0.298 | Neurotensin receptor agonist | 0.298 0.014 CID_903 0.282 0.016 CID_1864 | CID_903 | |
| 0.255 | 0.007 | 0.255 | Falcipain 3 inhibitor | 0.241 0.009 CID_903 0.231 0.01 CID_1864 | ||
| 0.343 | 0.103 | 0.436 | Histamine release inhibitor | 0.436 0.057 CID_903 0.394 0.079 CID_1864 0.311 0.118 CID_131769970 | CID_903 | |
| 0.333 | 0.095 | 0.333 | Calpain 2 inhibitor | 0.306 0.11 CID_903 | ||
| 0.29 | 0.055 | 0.392 | Antiamyloidogenic | 0.302 0.051 CID_903 0.392 0.03 CID_1864 | CID_1864 | |
| 0.238 | 0.005 | 0.238 | 5 Hydroxytryptamine 1D antagonist | 0.137 0.014 CID_903 0.105 0.021 CID_1864 | ||
| 0.273 | 0.044 | 0.273 | Sigma receptor agonist | 0.24 0.051 CID_903 0.251 0.048 CID_1864 | ||
| 0.252 | 0.027 | 0.252 | 3C-like protease (Human coronavirus) inhibitor | 0.193 0.056 CID_903 0.15 0.101 CID_1864 | ||
| 0.293 | 0.07 | 0.318 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.3 0.064 CID_903 0.318 0.052 CID_1864 | CID_1864 | |
| 0.224 | 0.017 | 0.238 | Antibacterial (Helicobacter pylori) | 0.217 0.018 CID_903 0.238 0.014 CID_1864 | CID_1864 | |
| 0.296 | 0.09 | 0.554 | Vasodilator, coronary | 0.266 0.119 CID_903 0.319 0.073 CID_1864 0.554 0.01 CID_131769970 | CID_131769970 | |
| 0.273 | 0.07 | 0.273 | Aryl hydrocarbon receptor agonist | 0.227 0.089 CID_903 0.245 0.081 CID_1864 | ||
| 0.238 | 0.038 | 0.258 | Lipocortins synthesis antagonist | 0.258 0.031 CID_903 0.231 0.04 CID_1864 0.162 0.089 CID_131769970 | CID_903 | |
| 0.219 | 0.02 | 0.241 | GABA C receptor rho-2 antagonist | 0.241 0.014 CID_903 0.21 0.024 CID_1864 | CID_903 | |
| 0.246 | 0.048 | 0.521 | Peroxidase inhibitor | 0.521 0.008 CID_903 0.353 0.028 CID_1864 | CID_903 | |
| 0.208 | 0.013 | 0.24 | 5 Hydroxytryptamine 3A agonist | 0.24 0.006 CID_903 0.134 0.045 CID_1864 | CID_903 | |
| 0.213 | 0.021 | 0.217 | Alpha 2b adrenoreceptor antagonist | 0.158 0.035 CID_903 0.217 0.02 CID_1864 | CID_1864 | |
| 0.246 | 0.054 | 0.381 | Peptidyltransferase inhibitor | 0.293 0.027 CID_903 0.279 0.033 CID_1864 0.381 0.008 CID_131769970 | CID_131769970 | |
| 0.194 | 0.004 | 0.194 | 5 Hydroxytryptamine 2A agonist | 0.155 0.005 CID_903 0.13 0.007 CID_1864 | ||
| 0.312 | 0.123 | 0.397 | 15-Lipoxygenase inhibitor | 0.392 0.078 CID_903 0.397 0.076 CID_1864 | CID_1864 | |
| 0.197 | 0.008 | 0.197 | 5 Hydroxytryptamine 1B antagonist | 0.113 0.019 CID_903 0.081 0.033 CID_1864 | ||
| 0.252 | 0.066 | 0.356 | Tyrosine 3 hydroxylase inhibitor | 0.356 0.015 CID_903 0.274 0.048 CID_1864 | CID_903 | |
| 0.246 | 0.061 | 0.272 | Neuropeptide Y2 antagonist | 0.272 0.036 CID_903 0.189 0.14 CID_1864 | CID_903 | |
| 0.182 | 0.004 | 0.242 | Beta 3 adrenoreceptor antagonist | 0.242 0.003 CID_903 0.199 0.004 CID_1864 | CID_903 | |
| 0.276 | 0.101 | 0.329 | Sodium/bile acid cotransporter inhibitor | 0.329 0.054 CID_903 0.304 0.076 CID_1864 0.267 0.11 CID_131769970 | CID_903 | |
| 0.181 | 0.012 | 0.259 | Prolactin inhibitor | 0.259 0.004 CID_903 0.173 0.014 CID_1864 | CID_903 | |
| 0.184 | 0.018 | 0.184 | 5 Hydroxytryptamine 1 antagonist | 0.084 0.044 CID_903 0.077 0.049 CID_1864 | ||
| 0.191 | 0.027 | 0.21 | CF transmembrane conductance regulator agonist | 0.21 0.017 CID_903 0.164 0.054 CID_1864 | CID_903 | |
| 0.184 | 0.025 | 0.222 | Cyclooxygenase 3 inhibitor | 0.183 0.026 CID_903 0.181 0.027 CID_1864 0.222 0.013 CID_131769970 | CID_131769970 | |
| 0.212 | 0.054 | 0.273 | Growth hormone agonist | 0.273 0.038 CID_903 0.191 0.062 CID_1864 | CID_903 | |
| 0.178 | 0.021 | 0.178 | 5 Hydroxytryptamine 2C antagonist | 0.097 0.047 CID_903 0.103 0.043 CID_1864 | ||
| 0.16 | 0.004 | 0.16 | 5 Hydroxytryptamine 1B agonist | 0.156 0.004 CID_903 0.101 0.007 CID_1864 | ||
| 0.178 | 0.028 | 0.223 | Adenylate cyclase stimulant | 0.223 0.007 CID_903 0.21 0.01 CID_1864 0.163 0.043 CID_131769970 | CID_903 | |
| 0.233 | 0.086 | 0.281 | Superoxide dismutase inhibitor | 0.258 0.07 CID_903 0.281 0.058 CID_1864 | CID_1864 | |
| 0.153 | 0.007 | 0.153 | 5 Hydroxytryptamine 5 antagonist | 0.099 0.015 CID_903 0.072 0.025 CID_1864 | ||
| 0.167 | 0.026 | 0.171 | Alpha 2c adrenoreceptor antagonist | 0.131 0.042 CID_903 0.171 0.024 CID_1864 | CID_1864 | |
| 0.207 | 0.067 | 0.219 | Insulin sensitizer | 0.219 0.056 CID_903 0.201 0.072 CID_1864 | CID_903 | |
| 0.258 | 0.119 | 0.35 | Apoptosis antagonist | 0.299 0.086 CID_903 0.312 0.077 CID_1864 0.35 0.056 CID_131769970 | CID_131769970 | |
| 0.143 | 0.004 | 0.143 | Melatonin 3 antagonist | 0.105 0.005 CID_903 0.055 0.006 CID_1864 | ||
| 0.235 | 0.097 | 0.238 | Gastrin inhibitor | 0.238 0.094 CID_903 0.194 0.159 CID_1864 | CID_903 | |
| 0.178 | 0.041 | 0.21 | Histone deacetylase SIRT1 inhibitor | 0.21 0.027 CID_903 0.175 0.042 CID_1864 | CID_903 | |
| 0.162 | 0.025 | 0.205 | Heat shock protein 70 antagonist | 0.176 0.014 CID_903 0.167 0.02 CID_1864 0.205 0.005 CID_131769970 | CID_131769970 | |
| 0.145 | 0.008 | 0.145 | 5 Hydroxytryptamine 5A antagonist | 0.107 0.014 CID_903 0.078 0.025 CID_1864 | ||
| 0.179 | 0.043 | 0.179 | Nav1.2 sodium channel blocker | 0.149 0.058 CID_903 | ||
| 0.152 | 0.02 | 0.152 | 5 Hydroxytryptamine 1A antagonist | 0.072 0.045 CID_903 0.07 0.046 CID_1864 | ||
| 0.255 | 0.124 | 0.493 | Transcription factor NF kappa B inhibitor | 0.313 0.088 CID_903 0.377 0.069 CID_1864 0.493 0.045 CID_131769970 | CID_131769970 | |
| 0.187 | 0.062 | 0.187 | Tumour necrosis factor antagonist | 0.172 0.075 CID_1864 | ||
| 0.212 | 0.088 | 0.371 | Free radical scavenger | 0.316 0.048 CID_903 0.371 0.034 CID_1864 0.315 0.048 CID_131769970 | CID_1864 | |
| 0.139 | 0.018 | 0.139 | 5 Hydroxytryptamine 1F antagonist | 0.124 0.022 CID_903 0.084 0.04 CID_1864 | ||
| 0.125 | 0.005 | 0.125 | 5 Hydroxytryptamine 7 agonist | 0.083 0.011 CID_903 0.083 0.011 CID_1864 | ||
| 0.175 | 0.055 | 0.213 | Melanin inhibitor | 0.205 0.039 CID_903 0.213 0.036 CID_1864 | CID_1864 | |
| 0.209 | 0.09 | 0.358 | Angiogenesis stimulant | 0.265 0.063 CID_903 0.254 0.068 CID_1864 0.358 0.03 CID_131769970 | CID_131769970 | |
| 0.127 | 0.009 | 0.151 | Beta adrenoreceptor antagonist | 0.151 0.006 CID_903 0.146 0.006 CID_1864 | CID_903 | |
| 0.132 | 0.02 | 0.216 | Adrenaline agonist | 0.216 0.005 CID_903 0.178 0.009 CID_1864 | CID_903 | |
| 0.118 | 0.008 | 0.15 | GABA B receptor agonist | 0.15 0.004 CID_903 0.138 0.005 CID_1864 | CID_903 | |
| 0.153 | 0.045 | 0.162 | Proteasome inhibitor | 0.162 0.04 CID_903 0.145 0.049 CID_1864 | CID_903 | |
| 0.137 | 0.029 | 0.147 | Breast cancer-resistant protein inhibitor | 0.104 0.052 CID_903 0.147 0.025 CID_1864 | CID_1864 | |
| 0.111 | 0.004 | 0.111 | 5 Hydroxytryptamine 1D agonist | 0.088 0.005 CID_903 0.03 0.019 CID_1864 | ||
| 0.117 | 0.013 | 0.117 | Bombesin 1 receptor agonist | 0.114 0.014 CID_903 0.092 0.02 CID_1864 | ||
| 0.109 | 0.007 | 0.119 | Cholecystokinin A antagonist | 0.119 0.006 CID_903 0.076 0.013 CID_1864 | CID_903 | |
| 0.108 | 0.008 | 0.115 | Histone deacetylase 7 inhibitor | 0.115 0.007 CID_903 0.059 0.015 CID_1864 | CID_903 | |
| 0.109 | 0.009 | 0.131 | Beta 1 adrenoreceptor antagonist | 0.131 0.006 CID_903 0.123 0.007 CID_1864 | CID_903 | |
| 0.145 | 0.051 | 0.145 | 5 Hydroxytryptamine antagonist | |||
| 0.205 | 0.111 | 0.293 | DNA damaging | 0.211 0.107 CID_903 0.293 0.06 CID_1864 0.179 0.135 CID_131769970 | CID_1864 | |
| 0.139 | 0.046 | 0.139 | 5 Hydroxytryptamine 2B antagonist | 0.098 0.086 CID_903 0.103 0.079 CID_1864 | ||
| 0.135 | 0.042 | 0.147 | Photosensitizer | 0.147 0.033 CID_903 0.136 0.041 CID_1864 | CID_903 | |
| 0.099 | 0.008 | 0.115 | Cholecystokinin antagonist | 0.115 0.007 CID_903 0.066 0.016 CID_1864 | CID_903 | |
| 0.116 | 0.025 | 0.15 | Somatostatin 1 agonist | 0.15 0.014 CID_903 0.107 0.029 CID_1864 | CID_903 | |
| 0.22 | 0.13 | 0.314 | 12-Lipoxygenase inhibitor | 0.296 0.082 CID_903 0.314 0.072 CID_1864 | CID_1864 | |
| 0.12 | 0.03 | 0.155 | Histamine N-methyltransferase inhibitor | 0.155 0.013 CID_903 | CID_903 | |
| 0.129 | 0.042 | 0.129 | Butyrylcholinesterase inhibitor | 0.098 0.063 CID_903 0.103 0.06 CID_1864 | ||
| 0.125 | 0.041 | 0.21 | Carbonic anhydrase III inhibitor | 0.21 0.014 CID_903 0.194 0.017 CID_1864 | CID_903 | |
| 0.143 | 0.059 | 0.218 | NADPH oxidase inhibitor | 0.159 0.049 CID_903 0.218 0.029 CID_1864 | CID_1864 | |
| 0.134 | 0.051 | 0.134 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.137 | 0.055 | 0.159 | Histone deacetylase class III inhibitor | 0.159 0.037 CID_903 0.124 0.066 CID_1864 | CID_903 | |
| 0.108 | 0.026 | 0.134 | Glycine receptor antagonist | 0.134 0.012 CID_903 0.115 0.021 CID_1864 | CID_903 | |
| 0.124 | 0.044 | 0.152 | Carbonic anhydrase XV inhibitor | 0.152 0.03 CID_903 0.131 0.039 CID_1864 | CID_903 | |
| 0.09 | 0.011 | 0.09 | Cyclin D1 inhibitor | 0.071 0.027 CID_903 0.077 0.021 CID_1864 | ||
| 0.141 | 0.063 | 0.236 | Tubulin antagonist | 0.236 0.028 CID_1864 | CID_1864 | |
| 0.121 | 0.044 | 0.124 | Falcipain inhibitor | 0.124 0.042 CID_903 0.098 0.056 CID_1864 | CID_903 | |
| 0.086 | 0.01 | 0.135 | Beta 2 adrenoreceptor antagonist | 0.135 0.005 CID_903 0.111 0.007 CID_1864 | CID_903 | |
| 0.081 | 0.004 | 0.086 | Bombesin 1 receptor antagonist | 0.086 0.004 CID_903 0.067 0.005 CID_1864 | CID_903 | |
| 0.124 | 0.049 | 0.16 | Protein kinase C gamma inhibitor | 0.16 0.026 CID_903 0.133 0.042 CID_1864 | CID_903 | |
| 0.12 | 0.045 | 0.153 | Bronchodilator | 0.116 0.047 CID_903 0.153 0.03 CID_1864 | CID_1864 | |
| 0.104 | 0.031 | 0.104 | Histamine H2 receptor antagonist | 0.086 0.053 CID_903 | ||
| 0.079 | 0.008 | 0.079 | Histamine H2 receptor agonist | 0.073 0.009 CID_903 0.045 0.027 CID_1864 | ||
| 0.191 | 0.121 | 0.327 | Antioxidant | 0.284 0.068 CID_903 0.327 0.053 CID_1864 0.285 0.067 CID_131769970 | CID_1864 | |
| 0.098 | 0.028 | 0.122 | Estrogen-related receptor beta agonist | 0.122 0.009 CID_903 0.1 0.025 CID_1864 | CID_903 | |
| 0.078 | 0.008 | 0.101 | Histone deacetylase 9 inhibitor | 0.101 0.006 CID_903 0.049 0.016 CID_1864 | CID_903 | |
| 0.129 | 0.06 | 0.204 | Adenylate cyclase inhibitor | 0.204 0.025 CID_903 0.142 0.05 CID_1864 0.2 0.026 CID_131769970 | CID_903 | |
| 0.113 | 0.045 | 0.116 | Falcipain 2 inhibitor | 0.116 0.044 CID_903 0.092 0.058 CID_1864 | CID_903 | |
| 0.09 | 0.023 | 0.09 | Histone deacetylase inhibitor | 0.089 0.024 CID_903 0.064 0.047 CID_1864 | ||
| 0.107 | 0.041 | 0.107 | Toll-Like receptor 3 antagonist | |||
| 0.074 | 0.009 | 0.078 | Immunoglobulin Fc receptor antagonist | 0.078 0.007 CID_903 0.063 0.019 CID_1864 | CID_903 | |
| 0.189 | 0.127 | 0.43 | Immunostimulant | 0.304 0.077 CID_903 0.226 0.106 CID_1864 0.43 0.041 CID_131769970 | CID_131769970 | |
| 0.09 | 0.028 | 0.109 | Sirtuin 1 inhibitor | 0.109 0.018 CID_903 0.087 0.03 CID_1864 | CID_903 | |
| 0.095 | 0.035 | 0.095 | Metalloproteinase-9 inhibitor | 0.088 0.039 CID_903 0.077 0.046 CID_1864 | ||
| 0.065 | 0.005 | 0.065 | Follicle-stimulating hormone agonist | 0.051 0.005 CID_903 0.05 0.005 CID_1864 | ||
| 0.178 | 0.119 | 0.227 | ErbB-1 antagonist | 0.169 0.135 CID_903 0.227 0.065 CID_1864 | CID_1864 | |
| 0.152 | 0.093 | 0.156 | Cyclin-dependent kinase 3 inhibitor | 0.156 0.083 CID_903 | CID_903 | |
| 0.167 | 0.108 | 0.173 | Growth factor agonist | 0.173 0.097 CID_903 0.168 0.105 CID_1864 | CID_903 | |
| 0.133 | 0.076 | 0.133 | Nav1.6 sodium channel blocker | |||
| 0.113 | 0.056 | 0.123 | MAO A inhibitor | 0.123 0.051 CID_903 0.108 0.059 CID_1864 | CID_903 | |
| 0.125 | 0.069 | 0.125 | Nav1.3 sodium channel blocker | |||
| 0.108 | 0.052 | 0.146 | GABA C receptor rho-1 antagonist | 0.146 0.023 CID_903 0.107 0.054 CID_1864 | CID_903 | |
| 0.101 | 0.046 | 0.101 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.067 | 0.012 | 0.067 | Growth hormone secretagogue receptor antagonist | 0.05 0.018 CID_903 | ||
| 0.109 | 0.055 | 0.109 | Gastric antisecretory | 0.094 0.073 CID_1864 | ||
| 0.068 | 0.014 | 0.073 | Bombesin antagonist | 0.073 0.011 CID_903 0.06 0.018 CID_1864 | CID_903 | |
| 0.072 | 0.019 | 0.088 | Bombesin 2 receptor antagonist | 0.088 0.015 CID_903 0.061 0.023 CID_1864 | CID_903 | |
| 0.124 | 0.074 | 0.124 | Acetylcholinesterase inhibitor | 0.118 0.079 CID_1864 | ||
| 0.062 | 0.012 | 0.062 | Benzodiazepine antagonist | |||
| 0.064 | 0.015 | 0.073 | Adenylate cyclase 1 inhibitor | 0.073 0.011 CID_903 0.043 0.037 CID_1864 | CID_903 | |
| 0.069 | 0.02 | 0.091 | Beta 2 adrenoreceptor agonist | 0.091 0.005 CID_903 0.08 0.009 CID_1864 | CID_903 | |
| 0.111 | 0.062 | 0.141 | Nav1.4 sodium channel blocker | 0.141 0.038 CID_903 0.102 0.072 CID_1864 | CID_903 | |
| 0.08 | 0.032 | 0.081 | Neutrophil collagenase inhibitor | 0.081 0.031 CID_903 0.065 0.045 CID_1864 | CID_903 | |
| 0.054 | 0.006 | 0.054 | GHS receptor antagonist | 0.046 0.009 CID_903 0.035 0.018 CID_1864 | ||
| 0.068 | 0.02 | 0.068 | Ryanodine receptor antagonist | 0.064 0.028 CID_1864 | ||
| 0.068 | 0.021 | 0.068 | 5 Hydroxytryptamine 2 agonist | 0.045 0.044 CID_903 | ||
| 0.069 | 0.022 | 0.069 | 5 Hydroxytryptamine 1A agonist | 0.044 0.034 CID_903 | ||
| 0.126 | 0.079 | 0.147 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.147 0.067 CID_903 0.107 0.096 CID_1864 | CID_903 | |
| 0.087 | 0.041 | 0.087 | Alpha 1b adrenoreceptor antagonist | 0.079 0.047 CID_1864 | ||
| 0.13 | 0.084 | 0.154 | Vascular endothelial growth factor 3 antagonist | 0.154 0.064 CID_1864 | CID_1864 | |
| 0.07 | 0.025 | 0.075 | Gonadotropin-releasing hormone receptor agonist | 0.075 0.021 CID_903 0.065 0.032 CID_1864 | CID_903 | |
| 0.12 | 0.075 | 0.12 | Cathepsin H inhibitor | 0.119 0.077 CID_903 | ||
| 0.081 | 0.036 | 0.081 | Amidase inhibitor | 0.075 0.042 CID_903 | ||
| 0.11 | 0.066 | 0.11 | GABA receptor agonist | 0.107 0.069 CID_903 | ||
| 0.092 | 0.047 | 0.103 | Granulocyte macrophage colony stimulating factor agonist | 0.103 0.032 CID_1864 | CID_1864 | |
| 0.091 | 0.047 | 0.091 | Factor XII inhibitor | 0.086 0.055 CID_903 0.081 0.065 CID_1864 | ||
| 0.07 | 0.027 | 0.09 | Histone deacetylase SIRT3 inhibitor | 0.09 0.013 CID_903 0.058 0.056 CID_1864 | CID_903 | |
| 0.059 | 0.017 | 0.065 | Melanocortin 1 antagonist | 0.065 0.016 CID_903 0.036 0.028 CID_1864 | CID_903 | |
| 0.086 | 0.047 | 0.09 | Metalloproteinase-2 inhibitor | 0.09 0.044 CID_903 0.078 0.055 CID_1864 | CID_903 | |
| 0.125 | 0.087 | 0.144 | Neurotrophic factor | 0.137 0.072 CID_903 0.144 0.065 CID_1864 | CID_1864 | |
| 0.055 | 0.016 | 0.055 | GHS receptor agonist | 0.051 0.019 CID_903 0.041 0.033 CID_1864 | ||
| 0.048 | 0.01 | 0.062 | Cholecystokinin B antagonist | 0.062 0.008 CID_903 0.033 0.019 CID_1864 | CID_903 | |
| 0.188 | 0.152 | 0.197 | Transcription factor STAT3 inhibitor | 0.197 0.138 CID_903 0.182 0.161 CID_1864 | CID_903 | |
| 0.132 | 0.097 | 0.153 | Phospholipase A2 inhibitor | 0.153 0.071 CID_903 0.124 0.111 CID_1864 | CID_903 | |
| 0.147 | 0.113 | 0.175 | Death-associated protein kinase 2 inhibitor | 0.175 0.06 CID_903 0.159 0.086 CID_1864 | CID_903 | |
| 0.194 | 0.159 | 0.268 | Hypoxia-inducible factor 1 alpha inhibitor | 0.206 0.144 CID_903 0.232 0.117 CID_1864 0.268 0.085 CID_131769970 | CID_131769970 | |
| 0.05 | 0.018 | 0.076 | Beta adrenoreceptor agonist | 0.076 0.005 CID_903 0.059 0.008 CID_1864 | CID_903 | |
| 0.053 | 0.02 | 0.053 | Histone deacetylase 8 inhibitor | 0.052 0.02 CID_903 0.041 0.028 CID_1864 | ||
| 0.058 | 0.025 | 0.058 | Metalloproteinase-3 inhibitor | 0.043 0.042 CID_903 | ||
| 0.049 | 0.017 | 0.053 | Gonadotropin-releasing hormone receptor antagonist | 0.053 0.015 CID_903 0.032 0.026 CID_1864 | CID_903 | |
| 0.052 | 0.02 | 0.064 | Growth hormone release inhibitor | 0.064 0.014 CID_903 0.047 0.024 CID_1864 | CID_903 | |
| 0.036 | 0.004 | 0.036 | Follicle-stimulating hormone antagonist | 0.032 0.005 CID_903 0.026 0.005 CID_1864 | ||
| 0.051 | 0.02 | 0.066 | Somatostatin 1 antagonist | 0.066 0.013 CID_903 0.044 0.023 CID_1864 | CID_903 | |
| 0.092 | 0.061 | 0.104 | Antiadrenergic | 0.076 0.075 CID_903 0.104 0.054 CID_1864 | CID_1864 | |
| 0.046 | 0.015 | 0.052 | Somatostatin 5 agonist | 0.052 0.012 CID_903 0.037 0.021 CID_1864 | CID_903 | |
| 0.055 | 0.024 | 0.056 | Melanocortin antagonist | 0.056 0.024 CID_903 0.044 0.037 CID_1864 | CID_903 | |
| 0.095 | 0.065 | 0.095 | Sphingomyelinase inhibitor | |||
| 0.109 | 0.079 | 0.163 | Interleukin 8 antagonist | 0.163 0.027 CID_903 0.145 0.038 CID_1864 | CID_903 | |
| 0.09 | 0.06 | 0.101 | Adrenaline antagonist | 0.101 0.053 CID_1864 | CID_1864 | |
| 0.052 | 0.022 | 0.052 | Melanocortin 4 antagonist | 0.052 0.022 CID_903 0.039 0.032 CID_1864 | ||
| 0.069 | 0.039 | 0.069 | Aryl hydrocarbon receptor antagonist | 0.061 0.051 CID_903 | ||
| 0.066 | 0.037 | 0.066 | Alpha 1d adrenoreceptor antagonist | |||
| 0.146 | 0.117 | 0.168 | Catenin beta inhibitor | 0.168 0.069 CID_903 0.143 0.123 CID_1864 | CID_903 | |
| 0.098 | 0.069 | 0.117 | Urease inhibitor | 0.117 0.048 CID_903 0.11 0.055 CID_1864 | CID_903 | |
| 0.045 | 0.018 | 0.068 | Somatostatin 4 agonist | 0.068 0.01 CID_903 0.039 0.023 CID_1864 | CID_903 | |
| 0.086 | 0.059 | 0.135 | Antineoplastic alkaloid | 0.115 0.04 CID_903 0.135 0.032 CID_1864 | CID_1864 | |
| 0.069 | 0.042 | 0.069 | Potassium channel (ATP-sensitive) blocker | |||
| 0.076 | 0.049 | 0.08 | Histone deacetylase SIRT2 inhibitor | 0.08 0.045 CID_903 | CID_903 | |
| 0.048 | 0.022 | 0.048 | Acetyl-CoA carboxylase inhibitor | 0.039 0.033 CID_903 | ||
| 0.059 | 0.033 | 0.059 | Matrix metalloproteinase (membrane-type) inhibitor | 0.051 0.044 CID_903 | ||
| 0.063 | 0.037 | 0.076 | Carbonic anhydrase stimulant | 0.076 0.028 CID_903 0.062 0.039 CID_1864 | CID_903 | |
| 0.118 | 0.093 | 0.145 | Vanilloid 1 agonist | 0.12 0.088 CID_903 0.145 0.044 CID_1864 | CID_1864 | |
| 0.044 | 0.02 | 0.053 | Cholecystokinin B agonist | 0.053 0.014 CID_903 0.04 0.023 CID_1864 | CID_903 | |
| 0.045 | 0.022 | 0.045 | Histone deacetylase class I inhibitor | 0.042 0.025 CID_903 | ||
| 0.061 | 0.038 | 0.061 | Cathepsin L inhibitor | 0.06 0.039 CID_903 | ||
| 0.104 | 0.081 | 0.123 | TRPA1 agonist | 0.123 0.055 CID_903 | CID_903 | |
| 0.128 | 0.105 | 0.128 | Neuropeptide Y1 antagonist | 0.126 0.108 CID_903 | ||
| 0.069 | 0.047 | 0.265 | Phenylalanine 4-hydroxylase inhibitor | 0.265 0.004 CID_903 0.106 0.023 CID_1864 | CID_903 | |
| 0.031 | 0.009 | 0.031 | Cholecystokinin agonist | 0.026 0.01 CID_903 0.019 0.013 CID_1864 | ||
| 0.104 | 0.084 | 0.104 | Beta amyloid protein antagonist | |||
| 0.196 | 0.176 | 0.265 | Caspase 3 stimulant | 0.265 0.1 CID_1864 0.22 0.143 CID_131769970 | CID_1864 | |
| 0.048 | 0.028 | 0.06 | Neuraminidase (Influenza A) inhibitor | 0.057 0.015 CID_903 0.053 0.02 CID_1864 0.06 0.013 CID_131769970 | CID_131769970 | |
| 0.064 | 0.044 | 0.064 | Calcium channel P-type blocker | |||
| 0.038 | 0.019 | 0.043 | Sirtuin 2 inhibitor | 0.043 0.015 CID_903 | CID_903 | |
| 0.049 | 0.031 | 0.057 | Endothelin-converting enzyme inhibitor | 0.057 0.026 CID_903 0.04 0.038 CID_1864 | CID_903 | |
| 0.054 | 0.036 | 0.054 | GABA A receptor antagonist | 0.054 0.036 CID_903 | ||
| 0.072 | 0.055 | 0.096 | Alpha 2a adrenoreceptor antagonist | 0.096 0.038 CID_1864 | CID_1864 | |
| 0.035 | 0.019 | 0.057 | Somatostatin agonist | 0.057 0.012 CID_903 | CID_903 | |
| 0.054 | 0.038 | 0.057 | GABA receptor antagonist | 0.057 0.034 CID_903 | CID_903 | |
| 0.247 | 0.232 | 0.277 | 5 Hydroxytryptamine release inhibitor | 0.277 0.192 CID_903 | CID_903 | |
| 0.064 | 0.049 | 0.064 | Matrix metalloproteinase inhibitor | |||
| 0.022 | 0.008 | 0.022 | Cholecystokinin A agonist | 0.019 0.009 CID_903 0.017 0.011 CID_1864 | ||
| 0.042 | 0.028 | 0.069 | Toll-Like receptor 2 agonist | 0.069 0.018 CID_903 0.044 0.026 CID_1864 | CID_903 | |
| 0.071 | 0.058 | 0.071 | Alpha 1 adrenoreceptor antagonist | |||
| 0.082 | 0.068 | 0.1 | Hematopoietic | 0.1 0.035 CID_903 0.08 0.073 CID_1864 0.08 0.073 CID_131769970 | CID_903 | |
| 0.055 | 0.042 | 0.055 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.096 | 0.083 | 0.156 | Mucolytic | 0.1 0.077 CID_903 0.137 0.04 CID_1864 0.156 0.029 CID_131769970 | CID_131769970 | |
| 0.096 | 0.084 | 0.159 | DOPA decarboxylase inhibitor | 0.159 0.017 CID_903 0.123 0.042 CID_1864 | CID_903 | |
| 0.098 | 0.086 | 0.103 | Electron transport complex I inhibitor | 0.103 0.076 CID_1864 | CID_1864 | |
| 0.06 | 0.048 | 0.081 | 5 Hydroxytryptamine 3 agonist | 0.081 0.026 CID_903 | CID_903 | |
| 0.188 | 0.177 | 0.212 | 5 Hydroxytryptamine uptake stimulant | 0.204 0.144 CID_903 0.212 0.13 CID_1864 | CID_1864 | |
| 0.145 | 0.135 | 0.164 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.164 0.111 CID_903 0.145 0.134 CID_1864 | CID_903 | |
| 0.034 | 0.024 | 0.034 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.092 | 0.082 | 0.166 | AMP-activated protein kinase stimulant | 0.129 0.042 CID_903 0.106 0.063 CID_1864 0.166 0.019 CID_131769970 | CID_131769970 | |
| 0.049 | 0.039 | 0.049 | Matrix metalloproteinase 1 inhibitor | |||
| 0.025 | 0.016 | 0.025 | 5 Hydroxytryptamine 4 agonist | |||
| 0.137 | 0.128 | 0.161 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.161 0.102 CID_903 | CID_903 | |
| 0.08 | 0.071 | 0.08 | Alpha adrenoreceptor antagonist | 0.08 0.071 CID_1864 | ||
| 0.023 | 0.014 | 0.024 | Bombesin agonist | 0.024 0.012 CID_903 | CID_903 | |
| 0.049 | 0.04 | 0.049 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.157 | 0.149 | 0.214 | Tumour necrosis factor alpha release inhibitor | 0.214 0.097 CID_1864 0.169 0.135 CID_131769970 | CID_1864 | |
| 0.037 | 0.03 | 0.037 | Substance P antagonist | |||
| 0.178 | 0.171 | 0.211 | Transcription factor STAT inhibitor | 0.211 0.122 CID_903 | CID_903 | |
| 0.031 | 0.023 | 0.043 | Somatostatin 5 antagonist | 0.043 0.016 CID_903 | CID_903 | |
| 0.073 | 0.066 | 0.119 | Carbonic anhydrase VI inhibitor | 0.119 0.03 CID_903 0.102 0.038 CID_1864 | CID_903 | |
| 0.023 | 0.016 | 0.035 | Beta 1 adrenoreceptor agonist | 0.035 0.006 CID_903 0.03 0.008 CID_1864 | CID_903 | |
| 0.037 | 0.03 | 0.037 | Cathepsin L1 inhibitor | |||
| 0.093 | 0.087 | 0.157 | Chelator | 0.157 0.033 CID_903 0.153 0.034 CID_1864 | CID_903 | |
| 0.028 | 0.022 | 0.028 | 5 Hydroxytryptamine 6 agonist | 0.027 0.025 CID_903 | ||
| 0.085 | 0.08 | 0.101 | Interleukin 1 beta converting enzyme inhibitor | 0.101 0.056 CID_903 | CID_903 | |
| 0.09 | 0.087 | 0.145 | Adenylate kinase inhibitor | 0.13 0.036 CID_903 0.091 0.084 CID_1864 0.145 0.028 CID_131769970 | CID_131769970 | |
| 0.054 | 0.051 | 0.054 | Dopamine D3 antagonist | |||
| 0.018 | 0.015 | 0.019 | Bombesin 3 receptor agonist | 0.019 0.013 CID_903 | CID_903 | |
| 0.12 | 0.117 | 0.134 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.134 0.102 CID_903 | CID_903 | |
| 0.024 | 0.022 | 0.051 | Somatostatin 2 antagonist | 0.051 0.015 CID_903 | CID_903 | |
| 0.029 | 0.027 | 0.03 | Growth hormone releasing factor agonist | 0.03 0.027 CID_903 | CID_903 | |
| 0.029 | 0.026 | 0.029 | Histone deacetylase 5 inhibitor | |||
| 0.055 | 0.053 | 0.055 | Dopamine D2 antagonist | |||
| 0.087 | 0.086 | 0.154 | Monophenol monooxygenase inhibitor | 0.153 0.046 CID_903 0.154 0.045 CID_1864 | CID_1864 | |
| 0.018 | 0.016 | 0.019 | Somatostatin 3 agonist | 0.019 0.012 CID_903 | CID_903 | |
| 0.116 | 0.115 | 0.158 | Thrombolytic | 0.153 0.079 CID_903 0.138 0.092 CID_1864 0.158 0.076 CID_131769970 | CID_131769970 | |
| 0.108 | 0.108 | 0.111 | Interleukin 1 antagonist | 0.111 0.103 CID_1864 | CID_1864 | |
| 0.021 | 0.02 | 0.028 | Somatostatin 4 antagonist | 0.028 0.013 CID_903 | CID_903 | |
| 0.023 | 0.023 | 0.03 | Melanocortin 3 antagonist | 0.03 0.02 CID_903 | CID_903 | |
| 0.059 | 0.059 | 0.066 | Prolactin release inhibitor | 0.066 0.032 CID_903 | CID_903 | |
| 0.026 | 0.026 | 0.028 | Peptide deformylase inhibitor | 0.028 0.024 CID_903 | CID_903 | |
| 0.023 | 0.024 | 0.027 | Urotensin II agonist | 0.027 0.018 CID_903 | CID_903 | |
| 0.05 | 0.051 | 0.052 | Alpha 1 adrenoreceptor agonist | 0.052 0.048 CID_1864 | CID_1864 | |
| 0.023 | 0.024 | 0.045 | Thyroid hormone agonist | 0.045 0.005 CID_903 0.025 0.019 CID_1864 | CID_903 | |
| 0.073 | 0.075 | 0.084 | Alpha 2 adrenoreceptor antagonist | 0.084 0.061 CID_1864 | CID_1864 | |
| 0.086 | 0.088 | 0.094 | Phosphodiesterase 6D inhibitor | 0.094 0.064 CID_903 | CID_903 | |
| 0.036 | 0.038 | 0.06 | Dopamine D2 agonist | 0.06 0.021 CID_903 0.06 0.021 CID_1864 | CID_1864 | |
| 0.052 | 0.055 | 0.064 | Glucagon-like peptide 1 agonist | 0.064 0.045 CID_903 | CID_903 | |
| 0.076 | 0.079 | 0.107 | CC chemokine 5 receptor agonist | 0.107 0.015 CID_903 | CID_903 | |
| 0.018 | 0.022 | 0.026 | Growth hormone releasing factor antagonist | 0.026 0.015 CID_903 | CID_903 | |
| 0.077 | 0.081 | 0.081 | 3C-Like protease (SARS coronavirus) inhibitor | 0.081 0.067 CID_903 | CID_903 | |
| 0.016 | 0.02 | 0.02 | Somatostatin 3 antagonist | 0.02 0.014 CID_903 | CID_903 | |
| 0.024 | 0.029 | 0.027 | Histone deacetylase class IV inhibitor | 0.027 0.026 CID_903 | CID_903 | |
| 0.024 | 0.029 | 0.027 | Histone deacetylase 11 inhibitor | 0.027 0.026 CID_903 | CID_903 | |
| 0.017 | 0.023 | 0.022 | Dopamine autoreceptor agonist | 0.022 0.018 CID_903 | CID_903 | |
| 0.016 | 0.022 | 0.021 | Melanocortin 1 agonist | 0.021 0.019 CID_903 | CID_903 | |
| 0.046 | 0.053 | 0.065 | Vanilloid 2 antagonist | 0.048 0.047 CID_903 0.065 0.018 CID_1864 | CID_1864 | |
| 0.045 | 0.052 | 0.113 | Beta tubulin antagonist | 0.113 0.019 CID_1864 | CID_1864 | |
| 0.08 | 0.087 | 0.107 | Protein kinase C zeta inhibitor | 0.107 0.043 CID_903 0.093 0.061 CID_1864 | CID_903 | |
| 0.02 | 0.027 | 0.024 | ICAM 1 antagonist | 0.024 0.013 CID_903 | CID_903 | |
| 0.104 | 0.111 | 0.189 | Lipid peroxidase inhibitor | 0.17 0.055 CID_903 0.189 0.046 CID_1864 0.137 0.078 CID_131769970 | CID_1864 | |
| 0.066 | 0.074 | 0.092 | Platelet growth factor antagonist | 0.092 0.046 CID_1864 | CID_1864 | |
| 0.007 | 0.015 | 0.019 | Beta 3 adrenoreceptor agonist | 0.019 0.005 CID_903 | CID_903 | |
| 0.117 | 0.126 | 0.128 | Thiol protease inhibitor | 0.128 0.101 CID_903 | CID_903 | |
| 0.049 | 0.059 | 0.077 | Neuraminidase inhibitor | 0.077 0.028 CID_903 0.069 0.034 CID_1864 0.073 0.031 CID_131769970 | CID_903 | |
| 0.045 | 0.059 | 0.051 | Bombesin 3 receptor antagonist | 0.051 0.045 CID_903 | CID_903 | |
| 0.055 | 0.069 | 0.075 | Neuraminidase (influenza) inhibitor | 0.075 0.03 CID_903 0.068 0.038 CID_1864 0.071 0.034 CID_131769970 | CID_903 | |
| 0.126 | 0.141 | 0.162 | Pyruvate kinase inhibitor | 0.162 0.106 CID_903 0.16 0.107 CID_1864 | CID_903 | |
| 0.013 | 0.027 | 0.018 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.018 0.015 CID_1864 | CID_1864 | |
| 0.064 | 0.079 | 0.095 | Macrophage migration inhibitory factor inhibitor | 0.09 0.042 CID_903 0.095 0.038 CID_1864 | CID_1864 | |
| 0.085 | 0.1 | 0.115 | Beta glucuronidase inhibitor | 0.115 0.051 CID_903 0.112 0.054 CID_1864 | CID_903 | |
| 0.04 | 0.056 | 0.047 | Protein kinase C epsilon inhibitor | 0.047 0.045 CID_903 | CID_903 | |
| 0.12 | 0.136 | 0.129 | LIM domain kinase 1 inhibitor | 0.129 0.122 CID_903 | CID_903 | |
| 0.004 | 0.022 | 0.01 | Thyroid hormone beta agonist | 0.01 0.005 CID_903 | CID_903 | |
| 0.035 | 0.055 | 0.052 | Neuropeptide agonist | 0.052 0.042 CID_903 | CID_903 | |
| 0.182 | 0.202 | 0.443 | Antithrombotic | 0.226 0.148 CID_903 0.193 0.186 CID_1864 0.443 0.039 CID_131769970 | CID_131769970 | |
| 0.052 | 0.074 | 0.068 | Carbonic anhydrase VA inhibitor | 0.068 0.048 CID_903 | CID_903 | |
| 0.11 | 0.132 | 0.121 | Aurora-C kinase inhibitor | 0.121 0.103 CID_903 | CID_903 | |
| 0.092 | 0.114 | 0.151 | Aldehyde dehydrogenase inhibitor | 0.149 0.048 CID_903 0.151 0.047 CID_131769970 | CID_131769970 | |
| 0.046 | 0.068 | 0.074 | Dopamine agonist | 0.068 0.046 CID_903 0.074 0.041 CID_1864 | CID_1864 | |
| 0.072 | 0.096 | 0.146 | Aminoacyl-tRNA synthetase inhibitor | 0.089 0.061 CID_903 0.146 0.02 CID_131769970 | CID_131769970 | |
| 0.105 | 0.131 | 0.129 | Papain-like protease (SARS coronavirus) inhibitor | 0.129 0.062 CID_903 0.124 0.072 CID_1864 | CID_903 | |
| 0.073 | 0.102 | 0.103 | Mediator release inhibitor | 0.103 0.066 CID_903 0.102 0.068 CID_1864 | CID_903 | |
| 0.012 | 0.044 | 0.022 | Estrogen-related receptor gamma agonist | 0.022 0.008 CID_903 | CID_903 | |
| 0.071 | 0.105 | 0.097 | Vanilloid agonist | 0.078 0.076 CID_903 0.097 0.036 CID_1864 | CID_1864 | |
| 0.031 | 0.066 | 0.049 | AICAR transformylase inhibitor | 0.049 0.024 CID_903 0.045 0.029 CID_131769970 | CID_903 | |
| 0.04 | 0.075 | 0.102 | Selectin antagonist | 0.061 0.048 CID_903 0.102 0.027 CID_131769970 | CID_131769970 | |
| 0.059 | 0.095 | 0.08 | Keratolytic | 0.08 0.048 CID_903 0.079 0.05 CID_1864 | CID_903 | |
| 0.117 | 0.153 | 0.14 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.14 0.129 CID_903 | CID_903 | |
| 0.066 | 0.103 | 0.099 | Platelet activating factor alpha antagonist | 0.099 0.06 CID_1864 | CID_1864 | |
| 0.08 | 0.117 | 0.139 | GABA C receptor antagonist | 0.139 0.037 CID_903 | CID_903 | |
| 0.139 | 0.176 | 0.319 | Interleukin agonist | 0.197 0.124 CID_903 0.319 0.039 CID_131769970 | CID_131769970 | |
| 0.139 | 0.176 | 0.191 | Spasmolytic | 0.166 0.149 CID_903 0.191 0.127 CID_1864 0.191 0.127 CID_131769970 | CID_131769970 | |
| 0.191 | 0.229 | 0.265 | Alpha-glucosidase inhibitor | 0.242 0.192 CID_903 0.265 0.179 CID_1864 | CID_1864 | |
| 0.138 | 0.176 | 0.381 | Cyclic AMP phosphodiesterase inhibitor | 0.157 0.141 CID_1864 0.381 0.019 CID_131769970 | CID_131769970 | |
| 0.034 | 0.073 | 0.077 | Alpha tubulin antagonist | 0.077 0.021 CID_1864 | CID_1864 | |
| 0.076 | 0.114 | 0.095 | Interleukin 12 antagonist | 0.095 0.062 CID_903 0.089 0.074 CID_1864 | CID_903 | |
| 0.215 | 0.254 | 0.402 | Apoptosis agonist | 0.237 0.229 CID_903 0.351 0.138 CID_1864 0.402 0.113 CID_131769970 | CID_131769970 | |
| 0.03 | 0.069 | 0.05 | Opioid mu receptor agonist | 0.05 0.029 CID_903 | CID_903 | |
| 0.071 | 0.111 | 0.242 | Expectorant | 0.111 0.057 CID_1864 0.242 0.014 CID_131769970 | CID_131769970 | |
| 0.043 | 0.084 | 0.061 | Carbonic anhydrase V inhibitor | 0.061 0.053 CID_903 | CID_903 | |
| 0.125 | 0.168 | 0.181 | Platelet aggregation inhibitor | 0.181 0.097 CID_1864 | CID_1864 | |
| 0.021 | 0.067 | 0.033 | Opioid delta receptor agonist | 0.033 0.028 CID_903 | CID_903 | |
| 0.06 | 0.107 | 0.109 | Opioid antagonist | 0.109 0.042 CID_903 | CID_903 | |
| 0.044 | 0.093 | 0.064 | Catalase inhibitor | 0.064 0.06 CID_903 | CID_903 | |
| 0.062 | 0.112 | 0.086 | Protein kinase C delta inhibitor | 0.086 0.068 CID_903 | CID_903 | |
| 0.082 | 0.134 | 0.164 | Alpha-N-acetylglucosaminidase inhibitor | 0.164 0.048 CID_903 0.102 0.099 CID_131769970 | CID_903 | |
| 0.09 | 0.144 | 0.124 | Transcription factor STAT6 inhibitor | 0.124 0.053 CID_903 | CID_903 | |
| 0.008 | 0.065 | 0.017 | Adenosine A2b receptor agonist | 0.017 0.008 CID_131769970 | CID_131769970 | |
| 0.027 | 0.085 | 0.064 | Carbonic anhydrase XIV inhibitor | 0.064 0.023 CID_131769970 | CID_131769970 | |
| 0.028 | 0.086 | 0.071 | Protein 50S ribosomal subunit inhibitor | 0.071 0.024 CID_131769970 | CID_131769970 | |
| 0.094 | 0.152 | 0.125 | Acetylcholine M1 receptor antagonist | 0.125 0.101 CID_903 | CID_903 | |
| 0.042 | 0.101 | 0.057 | CDC25B inhibitor | 0.057 0.055 CID_903 | CID_903 | |
| 0.036 | 0.096 | 0.088 | Opioid mu receptor antagonist | 0.088 0.036 CID_903 | CID_903 | |
| 0.126 | 0.187 | 0.154 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.154 0.127 CID_1864 | CID_1864 | |
| 0.008 | 0.069 | 0.022 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.022 0.013 CID_131769970 | CID_131769970 | |
| 0.033 | 0.094 | 0.048 | Protein kinase C eta inhibitor | 0.048 0.047 CID_903 | CID_903 | |
| 0.06 | 0.122 | 0.089 | HIV-1 integrase (Overall Integration) inhibitor | 0.089 0.066 CID_903 | CID_903 | |
| 0.064 | 0.126 | 0.089 | ATPase (Vacuolar H+) inhibitor | 0.089 0.059 CID_1864 | CID_1864 | |
| 0.029 | 0.091 | 0.083 | Opioid delta receptor antagonist | 0.083 0.035 CID_903 | CID_903 | |
| 0.068 | 0.131 | 0.11 | EphA2 antagonist | 0.11 0.065 CID_1864 | CID_1864 | |
| 0.077 | 0.141 | 0.114 | Bone formation stimulant | 0.114 0.091 CID_903 0.109 0.096 CID_1864 | CID_903 | |
| 0.04 | 0.105 | 0.089 | Histidine decarboxylase inhibitor | 0.089 0.037 CID_903 0.064 0.058 CID_1864 | CID_903 | |
| 0.023 | 0.088 | 0.053 | Carbonic anhydrase VB inhibitor | 0.053 0.041 CID_903 | CID_903 | |
| 0.067 | 0.131 | 0.113 | DNA intercalator | 0.113 0.062 CID_131769970 | CID_131769970 | |
| 0.02 | 0.088 | 0.081 | NMDA 2A receptor antagonist | 0.081 0.019 CID_903 | CID_903 | |
| 0.126 | 0.196 | 0.298 | Vasodilator | 0.174 0.128 CID_1864 0.298 0.049 CID_131769970 | CID_131769970 | |
| 0.044 | 0.116 | 0.067 | Topoisomerase II alpha inhibitor | 0.067 0.064 CID_1864 | CID_1864 | |
| 0.108 | 0.181 | 0.208 | Antimitotic | 0.208 0.079 CID_1864 | CID_1864 | |
| 0.007 | 0.081 | 0.018 | Adenosine A2 receptor agonist | 0.018 0.009 CID_131769970 | CID_131769970 | |
| 0.015 | 0.092 | 0.027 | Purinergic P2Y15 antagonist | 0.027 0.024 CID_131769970 | CID_131769970 | |
| 0.114 | 0.191 | 0.142 | ATPase inhibitor | 0.142 0.116 CID_1864 | CID_1864 | |
| 0.039 | 0.119 | 0.061 | Heat shock protein 90 beta antagonist | 0.054 0.051 CID_903 0.061 0.038 CID_1864 | CID_1864 | |
| 0.178 | 0.258 | 0.551 | Antibacterial | 0.293 0.141 CID_903 0.25 0.177 CID_1864 0.551 0.028 CID_131769970 | CID_131769970 | |
| 0.153 | 0.234 | 0.209 | Angiogenesis inhibitor | 0.209 0.159 CID_1864 | CID_1864 | |
| 0.097 | 0.179 | 0.121 | Hemostatic | 0.121 0.112 CID_131769970 | CID_131769970 | |
| 0.111 | 0.193 | 0.157 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.157 0.134 CID_1864 | CID_1864 | |
| 0.051 | 0.133 | 0.121 | Aminopeptidase B inhibitor | 0.121 0.052 CID_903 | CID_903 | |
| 0.167 | 0.254 | 0.269 | Interleukin 2 agonist | 0.259 0.109 CID_903 0.269 0.099 CID_131769970 | CID_131769970 | |
| 0.102 | 0.19 | 0.126 | Interferon gamma antagonist | 0.126 0.12 CID_1864 | CID_1864 | |
| 0.105 | 0.198 | 0.185 | Aldehyde oxidase inhibitor | 0.185 0.113 CID_903 0.147 0.141 CID_1864 | CID_903 | |
| 0.108 | 0.204 | 0.139 | MAP kinase kinase 4 inhibitor | 0.139 0.086 CID_903 | CID_903 | |
| 0.048 | 0.147 | 0.256 | Topoisomerase I inhibitor | 0.093 0.076 CID_1864 0.256 0.016 CID_131769970 | CID_131769970 | |
| 0.044 | 0.143 | 0.131 | NMDA receptor antagonist | 0.131 0.031 CID_903 | CID_903 | |
| 0.131 | 0.23 | 0.191 | Lipoxygenase inhibitor | 0.191 0.15 CID_1864 | CID_1864 | |
| 0.026 | 0.125 | 0.069 | Purinergic P2X2 antagonist | 0.069 0.046 CID_131769970 | CID_131769970 | |
| 0.126 | 0.225 | 0.276 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.276 0.032 CID_131769970 | CID_131769970 | |
| 0.039 | 0.143 | 0.072 | Analgesic, opioid | 0.072 0.059 CID_903 | CID_903 | |
| 0.004 | 0.111 | 0.031 | AMPA 1 receptor antagonist | 0.031 0.02 CID_903 | CID_903 | |
| 0.092 | 0.199 | 0.154 | Nitric oxide antagonist | 0.14 0.106 CID_1864 0.154 0.091 CID_131769970 | CID_131769970 | |
| 0.055 | 0.162 | 0.125 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.125 0.037 CID_131769970 | CID_131769970 | |
| 0.047 | 0.156 | 0.077 | Opioid kappa receptor antagonist | 0.077 0.062 CID_903 | CID_903 | |
| 0.078 | 0.187 | 0.115 | Protein kinase stimulant | 0.115 0.098 CID_131769970 | CID_131769970 | |
| 0.016 | 0.126 | 0.048 | Dopamine D5 agonist | 0.048 0.019 CID_903 | CID_903 | |
| 0.055 | 0.167 | 0.087 | MAP kinase kinase 7 inhibitor | 0.087 0.03 CID_903 | CID_903 | |
| 0.107 | 0.219 | 0.14 | Succinate dehydrogenase inhibitor | 0.14 0.132 CID_1864 | CID_1864 | |
| 0.089 | 0.201 | 0.287 | Platelet adhesion inhibitor | 0.287 0.038 CID_131769970 | CID_131769970 | |
| 0.029 | 0.141 | 0.05 | Heparanase inhibitor | 0.05 0.046 CID_131769970 | CID_131769970 | |
| 0.073 | 0.187 | 0.125 | Interleukin 4 antagonist | 0.124 0.08 CID_903 0.125 0.079 CID_1864 | CID_1864 | |
| 0.022 | 0.137 | 0.065 | Alcohol oxidase inhibitor | 0.065 0.032 CID_903 | CID_903 | |
| 0.052 | 0.171 | 0.111 | GABA C receptor agonist | 0.111 0.056 CID_903 | CID_903 | |
| 0.051 | 0.174 | 0.223 | UDP-glucose 4-epimerase inhibitor | 0.098 0.063 CID_903 0.223 0.015 CID_131769970 | CID_131769970 | |
| 0.131 | 0.253 | 0.218 | RNA-directed DNA polymerase inhibitor | 0.172 0.148 CID_903 0.187 0.121 CID_1864 0.218 0.076 CID_131769970 | CID_131769970 | |
| 0.025 | 0.15 | 0.053 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.053 0.039 CID_903 | CID_903 | |
| 0.149 | 0.274 | 0.22 | DNA directed DNA polymerase inhibitor | 0.22 0.212 CID_131769970 | CID_131769970 | |
| 0.051 | 0.179 | 0.08 | Triose-phosphate isomerase inhibitor | 0.08 0.076 CID_903 | CID_903 | |
| 0.018 | 0.151 | 0.039 | NMDA receptor subunit 3B antagonist | 0.039 0.036 CID_903 | CID_903 | |
| 0.017 | 0.153 | 0.031 | Estrogen-related receptor beta antagonist | 0.031 0.026 CID_903 | CID_903 | |
| 0.047 | 0.185 | 0.113 | Topoisomerase II inhibitor | 0.094 0.092 CID_1864 0.113 0.074 CID_131769970 | CID_131769970 | |
| 0.053 | 0.192 | 0.238 | DNA polymerase I inhibitor | 0.112 0.075 CID_1864 0.238 0.019 CID_131769970 | CID_131769970 | |
| 0.054 | 0.196 | 0.113 | Alkylator | 0.113 0.075 CID_131769970 | CID_131769970 | |
| 0.102 | 0.247 | 0.155 | Phospholipase C inhibitor | 0.151 0.105 CID_903 0.155 0.097 CID_131769970 | CID_131769970 | |
| 0.082 | 0.23 | 0.186 | Insulin secretagoues | 0.186 0.044 CID_131769970 | CID_131769970 | |
| 0.031 | 0.18 | 0.065 | Aminopeptidase I inhibitor | 0.065 0.061 CID_903 | CID_903 | |
| 0.06 | 0.215 | 0.212 | Cytidine deaminase inhibitor | 0.212 0.042 CID_131769970 | CID_131769970 | |
| 0.009 | 0.165 | 0.037 | Phosphoglycerate kinase inhibitor | 0.037 0.023 CID_131769970 | CID_131769970 | |
| 0.095 | 0.256 | 0.162 | Neurotrophic factor enhancer | 0.162 0.121 CID_903 | CID_903 | |
| 0.025 | 0.192 | 0.085 | Porphobilinogen synthase inhibitor | 0.085 0.044 CID_903 | CID_903 | |
| 0.015 | 0.183 | 0.073 | NMDA 2 receptor antagonist | 0.073 0.048 CID_903 | CID_903 | |
| 0.035 | 0.206 | 0.123 | M18 aspartyl aminopeptidase inhibitor | 0.123 0.068 CID_1864 | CID_1864 | |
| 0.009 | 0.182 | 0.042 | Sodium/glucose cotransporter inhibitor | 0.042 0.006 CID_131769970 | CID_131769970 | |
| 0.082 | 0.263 | 0.235 | Platelet antagonist | 0.235 0.079 CID_131769970 | CID_131769970 | |
| 0.05 | 0.232 | 0.093 | Transcription factor NF kappa B stimulant | 0.093 0.046 CID_131769970 | CID_131769970 | |
| 0.098 | 0.286 | 0.321 | Hypoglycemic | 0.321 0.046 CID_131769970 | CID_131769970 | |
| 0.033 | 0.223 | 0.092 | Glutamate dehydrogenase inhibitor | 0.092 0.035 CID_131769970 | CID_131769970 | |
| 0.006 | 0.196 | 0.048 | Sodium/glucose cotransporter 2 inhibitor | 0.048 0.007 CID_131769970 | CID_131769970 | |
| 0.075 | 0.267 | 0.14 | DNA repair enzyme inhibitor | 0.14 0.042 CID_131769970 | CID_131769970 | |
| 0.034 | 0.229 | 0.068 | Adenosine A3 receptor antagonist | 0.068 0.063 CID_131769970 | CID_131769970 | |
| 0.064 | 0.26 | 0.134 | Cell wall synthesis inhibitor | 0.115 0.107 CID_903 0.134 0.081 CID_131769970 | CID_131769970 | |
| 0.073 | 0.271 | 0.223 | Hepatoprotectant | 0.223 0.053 CID_131769970 | CID_131769970 | |
| 0.104 | 0.316 | 0.363 | DNA synthesis inhibitor | 0.363 0.028 CID_131769970 | CID_131769970 | |
| 0.065 | 0.284 | 0.197 | Hexokinase inhibitor | 0.197 0.037 CID_131769970 | CID_131769970 | |
| 0.012 | 0.232 | 0.055 | Adenosine A1 receptor antagonist | 0.055 0.044 CID_131769970 | CID_131769970 | |
| 0.042 | 0.267 | 0.112 | NADH dehydrogenase inhibitor | 0.112 0.034 CID_131769970 | CID_131769970 | |
| 0.031 | 0.285 | 0.115 | Creatine kinase inhibitor | 0.115 0.045 CID_903 | CID_903 | |
| 0.09 | 0.363 | 0.229 | Cholesterol antagonist | 0.229 0.141 CID_131769970 | CID_131769970 | |
| 0.086 | 0.366 | 0.312 | Immunosuppressant | 0.312 0.108 CID_131769970 | CID_131769970 | |
| 0.043 | 0.334 | 0.118 | Estrogen antagonist | 0.118 0.059 CID_903 | CID_903 | |
| 0.015 | 0.311 | 0.035 | Antibiotic Aminoglycoside-like | 0.035 0.028 CID_131769970 | CID_131769970 | |
| 0.027 | 0.353 | 0.064 | Adenine nucleotide translocase inhibitor | 0.064 0.022 CID_131769970 | CID_131769970 | |
| 0.002 | 0.346 | 0.014 | Purinergic P2 agonist | 0.014 0.011 CID_131769970 | CID_131769970 | |
| 0.002 | 0.346 | 0.014 | Purinergic receptor agonist | 0.014 0.011 CID_131769970 | CID_131769970 | |
| 0.005 | 0.365 | 0.019 | Adenosine A3 receptor agonist | 0.019 0.009 CID_131769970 | CID_131769970 | |
| 0.027 | 0.391 | 0.102 | Estrogen receptor beta antagonist | 0.102 0.061 CID_903 | CID_903 | |
| 0.005 | 0.399 | 0.016 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.016 0.009 CID_131769970 | CID_131769970 | |
| 0.068 | 0.49 | 0.221 | Immunomodulator | 0.221 0.14 CID_131769970 | CID_131769970 | |
| 0.019 | 0.501 | 0.113 | Uric acid excretion stimulant | 0.113 0.042 CID_131769970 | CID_131769970 | |
| 0.01 | 0.498 | 0.033 | Purinergic P2Y2 antagonist | 0.033 0.025 CID_131769970 | CID_131769970 | |
| 0.055 | 0.618 | 0.397 | Cyclophilin D inhibitor | 0.397 0.093 CID_131769970 | CID_131769970 | |
| 0.003 | 0.587 | 0.035 | Adenosine A1 receptor agonist | 0.035 0.009 CID_131769970 | CID_131769970 | |
| 0.002 | 0.923 | 0.024 | Purinergic P2X agonist | 0.024 0.021 CID_131769970 | CID_131769970 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |